Login / Signup

All patients with AML over 60 years of age should not be offered early allogeneic stem cell transplantation.

H Joachim Deeg
Published in: Blood advances (2021)
Keyphrases
  • stem cell transplantation
  • high dose
  • acute myeloid leukemia
  • low dose
  • acute lymphoblastic leukemia